Jun 20, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.12 in the latest trading session, marking a -0.73% move from the prior day.
Jun 20, 2019 - Buying stocks that have declined to bargain levels due to negative headlines and sentiment can pay off big.Mylan and Teva shares are extremely oversold and now trade for just about 4 times earnings.Bo
Jun 18, 2019 - Jazz Pharmaceuticals' (JAZZ) recently approved sleep drug, Sunosi, receives schedule IV designation under controlled substance list from the Drug Enforcement Agency.
Jun 18, 2019 - TEVA's generic revenues are surprisingly resilient against Medicare reform.The company's top notch pipeline and product launches have the ability to offset the generic drug apocalypse.Investor capitul
Jun 17, 2019 - Here are the biggest calls on Wall Street on Monday
Jun 13, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.62 in the latest trading session, marking a -1.03% move from the prior day.
Jun 12, 2019 - Names on the move ahead of the open.
Jun 12, 2019 - Teva Pharmaceutical Industries (TEVA -4.2%) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the cont
Jun 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.26 in the latest trading session, marking a -1.59% move from the prior day.
Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.